METIMYD OPH SUS 5 MG
PREDNISOLONE ACETATE : 5 MG SULFACETAMIDE SODIUM : 100 MG · DIN 00177024 · SCHERING-PLOUGH CANADA INC
Health Canada status: CANCELLED POST MARKET
What is METIMYD OPH SUS?
METIMYD OPH SUS 5 MG contains PREDNISOLONE ACETATE : 5 MG SULFACETAMIDE SODIUM : 100 MG. It is listed in the Health Canada Drug Product Database under DIN 00177024, held by SCHERING-PLOUGH CANADA INC, supplied as SUSPENSION for OPHTHALMIC administration. Health Canada currently lists it as cancelled post market, status dated 22-Jul-1999. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 00177024 |
|---|---|
| Brand name | METIMYD OPH SUS |
| Generic / active ingredient | PREDNISOLONE ACETATE : 5 MG SULFACETAMIDE SODIUM : 100 MG |
| Manufacturer | SCHERING-PLOUGH CANADA INC |
| Strength | 5 MG |
| Dosage form | SUSPENSION |
| Route of administration | OPHTHALMIC |
| Schedule | Prescription |
| ATC code | S01CA02 PREDNISOLONE AND ANTIINFECTIVES |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 22-Jul-1999 |
What can be used instead?
Other Canadian products sharing ATC code S01CA02 PREDNISOLONE AND ANTIINFECTIVES. 0 of 8 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| BLEPHAMIDE | 10 % | DROPS | ALLERGAN INC | CANCELLED POST MARKET | DIN 00807788 |
| BLEPHAMIDE S.O.P. | 0.2 % | OINTMENT | ALLERGAN INC | CANCELLED POST MARKET | DIN 00307246 |
| DIOPTIMYD OINTMENT | 5 MG | OINTMENT | STERI-MED PHARMA INC. | APPROVED | DIN 02023784 |
| ODAN-CIDE | 5 MG | SOLUTION | ODAN LABORATORIES LTD | DORMANT | DIN 00630640 |
| PREDNISOLONE/SULFACETAMIDE | 0.5 % | SUSPENSION | PHARMA STULLN INC. | DORMANT | DIN 02023814 |
| VASOCIDIN OPHTHALMIC SOLUTION | 100 MG | SOLUTION | NOVARTIS OPHTHALMICS NOVARTIS PHARMACEUTICALS (CANADA) INC | CANCELLED POST MARKET | DIN 02133342 |
| VASOCIDIN OPHTHALMIC SOLUTION | 2.5 MG | LIQUID | IOLAB PHARMACEUTICALS | CANCELLED POST MARKET | DIN 00843741 |
Who else supplies PREDNISOLONE AND ANTIINFECTIVES worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. PREDNISOLONE AND ANTIINFECTIVES appears in 190 registered pack listings across 10 markets, published on 9 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.